Translational Regulation of Utrophin by miRNAs
Open Access
- 27 December 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (12), e29376
- https://doi.org/10.1371/journal.pone.0029376
Abstract
Utrophin is the autosomal homolog of dystrophin, the product of the Duchenne Muscular Dystrophy (DMD) locus. Its regulation is of therapeutic interest as its overexpression can compensate for dystrophin's absence in animal models of DMD. The tissue distribution and transcriptional regulation of utrophin have been characterized extensively, and more recently translational control mechanisms that may underlie its complex expression patterns have begun to be identified. Using a variety of bioinformatic, molecular and cell biology techniques, we show that the muscle isoform utrophin-A is predominantly suppressed at the translational level in C2C12 myoblasts. The extent of translational inhibition is estimated to be ∼99% in C2C12 cells and is mediated by both the 5′- and 3′-UTRs of the utrophin-A mRNA. In this study we identify five miRNAs (let-7c, miR-150, miR-196b, miR-296-5p, miR-133b) that mediate the repression, and confirm repression by the previously identified miR-206. We demonstrate that this translational repression can be overcome by blocking the actions of miRNAs, resulting in an increased level of utrophin protein in C2C12 cells. The present study has identified key inhibitory mechanisms featuring miRNAs that regulate utrophin expression, and demonstrated that these mechanisms can be targeted to increase endogenous utrophin expression in cultured muscle cells. We suggest that miRNA-mediated inhibitory mechanisms could be targeted by methods similar to those described here as a novel strategy to increase utrophin expression as a therapy for DMD.Keywords
This publication has 30 references indexed in Scilit:
- Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation ScreeningPLOS ONE, 2011
- Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx MousePLOS ONE, 2011
- The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx miceHuman Molecular Genetics, 2009
- Functional Substitution by TAT-Utrophin in Dystrophin-Deficient MicePLoS Medicine, 2009
- IRES-Mediated Translation of Utrophin A Is Enhanced by Glucocorticoid Treatment in Skeletal Muscle CellsPLOS ONE, 2008
- Modulation of utrophin A mRNA stability in fast versus slow muscles via an AU-rich element and calcineurin signalingNucleic Acids Research, 2007
- Ets-2 Repressor Factor Silences Extrasynaptic Utrophin by N-Box–mediated Repression in Skeletal MuscleMolecular Biology of the Cell, 2007
- MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206The Journal of cell biology, 2006
- Pharmacological strategies for muscular dystrophyNature Reviews Drug Discovery, 2003
- Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoterJournal of Molecular Biology, 2001